Wealth Alliance Has $292,000 Holdings in Chemed Co. (NYSE:CHE)

Wealth Alliance cut its holdings in shares of Chemed Co. (NYSE:CHEFree Report) by 4.8% in the 3rd quarter, HoldingsChannel reports. The firm owned 561 shares of the company’s stock after selling 28 shares during the quarter. Wealth Alliance’s holdings in Chemed were worth $292,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Blume Capital Management Inc. purchased a new stake in shares of Chemed during the 2nd quarter valued at $43,000. Larson Financial Group LLC purchased a new stake in Chemed in the 3rd quarter worth about $44,000. Canada Pension Plan Investment Board purchased a new stake in Chemed in the 1st quarter worth about $46,000. Legacy Financial Group LLC purchased a new stake in Chemed in the 3rd quarter worth about $48,000. Finally, Covestor Ltd increased its holdings in Chemed by 334.6% in the 2nd quarter. Covestor Ltd now owns 113 shares of the company’s stock worth $61,000 after acquiring an additional 87 shares during the last quarter. 94.25% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CHE has been the subject of several recent research reports. Oppenheimer lifted their price objective on Chemed from $590.00 to $625.00 and gave the stock an “outperform” rating in a report on Wednesday, January 17th. Royal Bank of Canada lifted their price objective on Chemed from $576.00 to $604.00 and gave the stock an “outperform” rating in a report on Monday, October 30th.

View Our Latest Analysis on Chemed

Chemed Stock Performance

Shares of CHE opened at $589.00 on Monday. Chemed Co. has a fifty-two week low of $490.87 and a fifty-two week high of $610.35. The business has a 50-day moving average of $585.79 and a 200 day moving average of $549.96. The firm has a market cap of $8.87 billion, a P/E ratio of 36.47, a price-to-earnings-growth ratio of 2.88 and a beta of 0.43.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 1,500 shares of the firm’s stock in a transaction dated Monday, December 11th. The stock was sold at an average price of $572.77, for a total value of $859,155.00. Following the completion of the transaction, the chief executive officer now owns 111,468 shares in the company, valued at approximately $63,845,526.36. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Chemed news, CEO Kevin J. Mcnamara sold 1,500 shares of the firm’s stock in a transaction dated Monday, December 11th. The stock was sold at an average price of $572.77, for a total value of $859,155.00. Following the completion of the transaction, the chief executive officer now owns 111,468 shares in the company, valued at approximately $63,845,526.36. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Spencer S. Lee sold 1,000 shares of the firm’s stock in a transaction dated Monday, November 27th. The stock was sold at an average price of $579.73, for a total value of $579,730.00. Following the completion of the transaction, the executive vice president now owns 22,568 shares of the company’s stock, valued at approximately $13,083,346.64. The disclosure for this sale can be found here. 3.80% of the stock is owned by corporate insiders.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Further Reading

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.